Login
Navigate Fool.com
Will RGDX beat
the market?
Community Rating: Unrated

1.16 -0.03 (-2.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.19
Previous Close $1.19
Daily Range $1.15 - $1.20
52-Week Range $1.09 - $2.93
Market Cap $44.9M
P/E Ratio -4.83
Dividend (Yield) $0.00 (0.0%)
Volume 187,411
Average Daily Volume 681,960
Current FY EPS -$0.19

How do you think RGDX
will perform against the market?

Top RGDX Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Healthcare Stocks Retreating; Response Genetics Advancing After Becker Drapkin Trims Stake

Sector Update: Healthcare

Sector Update: Healthcare Shares Slipping in Pre-Bell

Sector Update: Healthcare

Healthcare Stocks Mostly Higher; Response Genetics Hits 52 Week Highs On Pathwork Deal; ONXX and AMG

Healthcare Stocks Mostly Higher; Response Genetics Hits 52 Week Highs On Pathwork Deal; ONXX and AMGN In The News

Sector Update: Healthcare

New Stock Coverage: Money Trees Growing in Forest City

Wall Street ratings agencies set the tone for today's stock market.

GlaxoSmithKline Buys 5 Million Shares in Response Genetics; Now Owns 15.2%

Response Genetics Test Target Patients That Xalkori Can Help

UPDATE 1-Response Genetics inks deal with Glaxo, shares soar

See More RGDX News...

Sector

Healthcare

Industry

Healthcare Information Services

RESPONSE GENETICS, INC. (RGDX) Description

The Company is engaged in the research and development of its own pharmacogenomic cancer diagnostic tests based on its proprietary technologies. Website: http://www.responsegenetics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks